New York State Common Retirement Fund
HBIO icon

New York State Common Retirement Fund’s Harvard Bioscience HBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,684
Closed -$9.53K – 3253
2025
Q1 		$9.53K Hold
1,684
– – ﹤0.01% 3084
2024
Q4 		$35.5K Hold
1,684
– – ﹤0.01% 2941
2024
Q3 		$45.3K Hold
1,684
– – ﹤0.01% 2898
2024
Q2 		$48K Sell
1,684
-16,151
-91% -$567K ﹤0.01% 3097
2024
Q1 		$756K Buy
17,835
+3,589
+25% +$161K ﹤0.01% 1912
2023
Q4 		$762K Buy
14,246
+446
+3% +$20.1K ﹤0.01% 1914
2023
Q3 		$593K Buy
13,800
+213
+2% +$9.83K ﹤0.01% 1982
2023
Q2 		$746K Buy
13,587
+4,041
+42% +$222K ﹤0.01% 1910
2023
Q1 		$401K Buy
9,546
+1,808
+23% +$53.6K ﹤0.01% 2286
2022
Q4 		$214K Buy
7,738
+10
+0.1% +$246 ﹤0.01% 2696
2022
Q3 		$198K Sell
7,728
-27
-0.3% -$893 ﹤0.01% 2775
2022
Q2 		$279K Sell
7,755
-1,035
-12% -$46.7K ﹤0.01% 2636
2022
Q1 		$546K Buy
8,790
+1,061
+14% +$62.8K ﹤0.01% 2364
2021
Q4 		$545K Sell
7,729
-85
-1% -$6.04K ﹤0.01% 2394
2021
Q3 		$545K Buy
7,814
+10
+0.1% +$796 ﹤0.01% 2415
2021
Q2 		$650K Sell
7,804
-1,469
-16% -$104K ﹤0.01% 2457
2021
Q1 		$506K Hold
9,273
– – ﹤0.01% 2457
2020
Q4 		$398K Sell
9,273
-145
-2% -$5.41K ﹤0.01% 2457
2020
Q3 		$283K Sell
9,418
-1,300
-12% -$43.7K ﹤0.01% 2497
2020
Q2 		$332K Buy
10,718
+3,470
+48% +$93.5K ﹤0.01% 2423
2020
Q1 		$160K Buy
7,248
+80
+1% +$2.17K ﹤0.01% 2569
2019
Q4 		$219K Hold
7,168
– – ﹤0.01% 2697
2019
Q3 		$220K Buy
7,168
+992
+16% +$24.7K ﹤0.01% 2719
2019
Q2 		$124K Sell
6,176
-2,362
-28% -$69.2K ﹤0.01% 3031
2019
Q1 		$368K Sell
8,538
-435
-5% -$15.8K ﹤0.01% 2446
2018
Q4 		$285K Sell
8,973
-305
-3% -$12K ﹤0.01% 2545
2018
Q3 		$487K Hold
9,278
– – ﹤0.01% 2417
2018
Q2 		$496K Buy
9,278
+1,900
+26% +$97.3K ﹤0.01% 2456
2018
Q1 		$369K Hold
7,378
– – ﹤0.01% 2485
2017
Q4 		$243K Sell
7,378
-1,179
-14% -$39.8K ﹤0.01% 2661
2017
Q3 		$321K Buy
+8,557
New +$253K ﹤0.01% 2576
2016
Q4 		– Sell
-633
Closed -$17K – 3130
2016
Q3 		$17K Sell
633
-287
-31% -$7.97K ﹤0.01% 3120
2016
Q2 		$26K Sell
920
-2,140
-70% -$68.1K ﹤0.01% 3129
2016
Q1 		$92K Hold
3,060
– – ﹤0.01% 2945
2015
Q4 		$106K Hold
3,060
– – ﹤0.01% 2994
2015
Q3 		$116K Buy
3,060
+1,333
+77% +$62K ﹤0.01% 2992
2015
Q2 		$98K Buy
+1,727
New +$98.3K ﹤0.01% 3108

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's HBIO Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 1,684 shares — an estimated $9.53K sold.

New York State Common Retirement Fund first reported a position in HBIO in Q2 2015 and held it in 37 quarters. The position peaked at $762K in Q4 2023. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,684 Harvard Bioscience shares in Q2 2025, an estimated $9.53K.
  • New York State Common Retirement Fund first reported a position in Harvard Bioscience in Q2 2015 and held it in 37 quarters.
  • New York State Common Retirement Fund's Harvard Bioscience position peaked at $762K in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.